Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
This article outlines scenarios where target date funds may be preferable to index funds in a 401(k), focusing on simplicity and risk management.
26,105 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
SandboxAQ CEO urges the United States to adopt a sovereign wealth fund strategy akin to Norway’s model. The call come...
A major fund trims a big stake in a tech name, sparking questions about risk, sector exposure, and portfolio resilien...
Institutional moves can quietly reshape a stock's risk and reward. This article looks at Levin's trim of O-I Glass an...
A dramatic security breach at a celebrity home isn’t just news. It offers practical financial lessons on protecting y...
A prominent billionaire hedge fund manager argues AI is becoming a daily utility and could spawn the first $10 trilli...
The latest 2027 COLA projections show a modest uptick, but many retirees still face a gap between benefits and expens...
A high-profile royalty dispute shows that winning rights doesn’t always cover legal bills. This article breaks down w...
If you’re wondering what the next year holds for stocks, this guide stays grounded. It blends data, real-world exampl...
When a Fed chair speaks about prices being too high, markets hear implications for rates. This article unpacks what t...
A bold policy idea could reshape how the U.S. handles digital assets. This article explains the proposed ARMA bill ai...
MetaMask steps into the AI era with an agent wallet designed for self-custody and safer automated DeFi trading. This ...